Results 41 to 50 of about 2,235 (133)

Global trends in typhoid and paratyphoid, and invasive non-typhoidal <i>salmonella</i>, and the burden of antimicrobial resistance: a trend analysis study from 1990 to 2021. [PDF]

Front Med (Lausanne)
Shi K, You T.
europepmc   +1 more source

Effective strategies for typhoid conjugate vaccine delivery: Health and economic insights from the 2015 Kampala outbreak. [PDF]

PLoS Negl Trop Dis
Lee Y, Salonga PKN, Son C, Jang G, Koh DH, Kim JH, Lee H.   +6 more
europepmc   +1 more source

FURTHER REMARKS ON THE MIXED TYPHOID + PARATYPHOID A + PARATYPHOID B VACCINE [PDF]

BMJ, 1915
openaire   +2 more sources

Multivalent vaccines for invasive <i>Salmonella</i> disease: need, rationale, and immunological foundations. [PDF]

Infect Immun
Mastroeni P, Rossi O, Micoli F.
europepmc   +1 more source

A systematised review and evidence synthesis on the broader societal impact of vaccines against Salmonella. [PDF]

NPJ Vaccines
Demirtas ED, Barnard R, Lee J, Jit M.
europepmc   +1 more source

An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants. [PDF]

Hum Vaccin Immunother
Mankar SV, Patel C, Chavan A, Modi R, Sarangi L, Tripathi VN, Dash DK, Narayan JP, Bandgar S, Kumar NR, Gill VK, Kakkar MK, Mitra M, Daultani P, Mittal R, Maithal K, Kansagra K, Parmar DV, Dutta T, Mahajan M, Desai S.   +20 more
europepmc   +1 more source

[Typhoid-paratyphoid vaccination].

Revista cubana de pediatria, 2003
openaire   +1 more source

XDR typhoid in Pakistan: A threat to global health security and a wake-up call for antimicrobial stewardship. [PDF]

PLoS Negl Trop Dis
Abdullah MA, Shaikh BT, Ashraf M, Khan SA.   +3 more
europepmc   +1 more source

Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy Infants. [PDF]

Viruses
Rao SN, Ambike D, Patil M, Mankar SV, Verma N, Hanumante N, Sarangi L, Mitra M, Preeti G, Deshmukh BJ, Nanoti G, Faridi MMA, Daultani P, Mittal R, Maithal K, Kansagra K, Parmar DV, Kunnathamman R, Elaiyaraja M, Dutta T, Mahajan M, Desai S.   +21 more
europepmc   +1 more source

Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries.

Vaccine
Ibarz-Pavon AB, Bielsky MC, Bose R, Cavaleri M, Crump JA, Hombach J, Kaslow DC, Khaman F, MacLennan CA, Mehring-LeDoare K, Pollard AJ, Quadri F, John J, Wilder-Smith A.   +13 more
europepmc   +1 more source